{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:44:20Z","timestamp":1792575860023,"version":"4.5.0"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202700"],"award-info":[{"award-number":["82202700"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82501064"],"award-info":[{"award-number":["82501064"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500899"],"award-info":[{"award-number":["82500899"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteoporosis is a systemic skeletal disorder characterized by reduced bone mineral density and heightened bone fragility, encompassing primary (senile and postmenopausal) and secondary (glucocorticoid-induced and diabetic) subtypes. Maintaining skeletal health relies on the dynamic balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. Among the multitude of factors orchestrating this bone remodeling process, epigenetics, which regulates gene expression via reversible chemical modifications without altering the primary DNA sequence, plays an essential role in maintaining bone homeostasis. While previous research has identified numerous epigenetic factors in bone metabolism, a comprehensive synthesis of their specific contributions to different osteoporosis subtypes and the corresponding therapeutic strategies remains lacking. This review outlines the major epigenetic mechanisms involved in bone metabolism, including DNA methylation, histone modifications, RNA modifications, and non-coding RNAs. Subsequently, we comprehensively elucidate how the dysregulation of these epigenetic landscapes drives the pathogenesis of distinct osteoporosis subtypes, emphasizing their roles in disrupting the osteoblast-osteoclast axis. Furthermore, we review emerging epigenetic-based therapeutics across distinct osteoporosis subtypes, ranging from systemic pharmacological inhibitors, such as DNA methyltransferase and histone demethylase inhibitors, to advanced delivery platforms targeting the skeletal microenvironment, such as engineered extracellular vesicles and functionalized nanocarriers. By integrating molecular mechanistic insights with these diverse therapeutic strategies, this review establishes a comprehensive framework for understanding the epigenetic heterogeneity in the pathogenesis and therapeutics of osteoporosis. Ultimately, it provides essential directions for future investigations, offering innovative epigenetic strategies to tackle various osteoporosis subtypes.<\/jats:p>","DOI":"10.1186\/s43556-026-00630-1","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:19:27Z","timestamp":1792574367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic regulatory networks in the pathogenesis and treatment of osteoporosis subtypes"],"prefix":"10.1186","volume":"7","author":[{"given":"Zhengda","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dequan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanwei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5781-2534","authenticated-orcid":false,"given":"Xiaoyi","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"630_CR1","doi-asserted-by":"publisher","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785\u201395. https:\/\/doi.org\/10.1001\/jama.285.6.785.","DOI":"10.1001\/jama.285.6.785"},{"key":"630_CR2","doi-asserted-by":"publisher","unstructured":"GBD 2021 Low Bone Mineral Density Collaborators. The global, regional, and national burden attributable to low bone mineral density, 1990\u20132020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021. Lancet Rheumatol. 2025;7:e873\u201394. https:\/\/doi.org\/10.1016\/S2665-9913(25)00105-5.","DOI":"10.1016\/S2665-9913(25)00105-5"},{"key":"630_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41413-022-00190-4","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang L, You X, Zhang L, Zhang C, Zou W. Mechanical regulation of bone remodeling. Bone Res. 2022;10:16. https:\/\/doi.org\/10.1038\/s41413-022-00190-4.","journal-title":"Bone Res"},{"key":"630_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/endrev\/bnab017","volume":"43","author":"M Jovanovic","year":"2022","unstructured":"Jovanovic M, Guterman-Ram G, Marini JC. Osteogenesis imperfecta: mechanisms and signaling pathways connecting classical and rare OI types. Endocr Rev. 2022;43:61\u201390. https:\/\/doi.org\/10.1210\/endrev\/bnab017.","journal-title":"Endocr Rev"},{"key":"630_CR5","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/ijms23031376","volume":"23","author":"CH Cheng","year":"2022","unstructured":"Cheng CH, Chen LR, Chen KH. Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci. 2022;23:1376. https:\/\/doi.org\/10.3390\/ijms23031376.","journal-title":"Int J Mol Sci"},{"key":"630_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41413-024-00342-8","volume":"12","author":"L Hu","year":"2024","unstructured":"Hu L, Chen W, Qian A, Li YP. Wnt\/\u03b2-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. Bone Res. 2024;12:39. https:\/\/doi.org\/10.1038\/s41413-024-00342-8.","journal-title":"Bone Res"},{"key":"630_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41413-024-00362-4","volume":"12","author":"BM El-Masri","year":"2024","unstructured":"El-Masri BM, Andreasen CM, Laursen KS, Kofod VB, Dahl XG, Nielsen MH, et al. Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect. Bone Res. 2024;12:62. https:\/\/doi.org\/10.1038\/s41413-024-00362-4.","journal-title":"Bone Res"},{"key":"630_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212139","volume":"25","author":"SH Hsu","year":"2024","unstructured":"Hsu SH, Chen LR, Chen KH. Primary osteoporosis induced by androgen and estrogen deficiency: the molecular and cellular perspective on pathophysiological mechanisms and treatments. Int J Mol Sci. 2024;25:12139. https:\/\/doi.org\/10.3390\/ijms252212139.","journal-title":"Int J Mol Sci"},{"key":"630_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","volume":"43","author":"PR Ebeling","year":"2022","unstructured":"Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F. Secondary osteoporosis. Endocr Rev. 2022;43:240\u2013313. https:\/\/doi.org\/10.1210\/endrev\/bnab028.","journal-title":"Endocr Rev"},{"key":"630_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102235","volume":"99","author":"S Huo","year":"2024","unstructured":"Huo S, Tang X, Chen W, Gan D, Guo H, Yao Q, et al. Epigenetic regulations of cellular senescence in osteoporosis. Ageing Res Rev. 2024;99:102235. https:\/\/doi.org\/10.1016\/j.arr.2024.102235.","journal-title":"Ageing Res Rev"},{"key":"630_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","volume":"128","author":"AD Goldberg","year":"2007","unstructured":"Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007;128:635\u20138. https:\/\/doi.org\/10.1016\/j.cell.2007.02.006.","journal-title":"Cell"},{"key":"630_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.746","volume":"12","author":"Y Xie","year":"2022","unstructured":"Xie Y, Han N, Li F, Wang L, Liu G, Hu M, et al. Melatonin enhances osteoblastogenesis of senescent bone marrow stromal cells through NSD2-mediated chromatin remodelling. Clin Transl Med. 2022;12:e746. https:\/\/doi.org\/10.1002\/ctm2.746.","journal-title":"Clin Transl Med"},{"key":"630_CR13","doi-asserted-by":"publisher","first-page":"1011725","DOI":"10.3389\/fcell.2022.1011725","volume":"10","author":"Z Xu","year":"2022","unstructured":"Xu Z, Yu Z, Chen M, Zhang M, Chen R, Yu H, et al. Mechanisms of estrogen deficiency-induced osteoporosis based on transcriptome and DNA methylation. Front Cell Dev Biol. 2022;10:1011725. https:\/\/doi.org\/10.3389\/fcell.2022.1011725.","journal-title":"Front Cell Dev Biol"},{"key":"630_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bone.2015.06.022","volume":"81","author":"JY Ko","year":"2015","unstructured":"Ko JY, Chuang PC, Ke HJ, Chen YS, Sun YC, Wang FS. MicroRNA-29a mitigates glucocorticoid induction of bone loss and fatty marrow by rescuing Runx2 acetylation. Bone. 2015;81:80\u20138. https:\/\/doi.org\/10.1016\/j.bone.2015.06.022.","journal-title":"Bone"},{"key":"630_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jare.2024.11.036","volume":"75","author":"F Wei","year":"2025","unstructured":"Wei F, Ruan B, Dong J, Yang B, Zhang G, Kelvin Yeung WK, et al. Asperosaponin VI inhibition of DNMT alleviates GPX4 suppression-mediated osteoblast ferroptosis and diabetic osteoporosis. J Adv Res. 2025;75:331\u201344. https:\/\/doi.org\/10.1016\/j.jare.2024.11.036.","journal-title":"J Adv Res"},{"key":"630_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41419-024-06521-z","volume":"15","author":"L Shan","year":"2024","unstructured":"Shan L, Yang X, Liao X, Yang Z, Zhou J, Li X, et al. Histone demethylase KDM7A regulates bone homeostasis through balancing osteoblast and osteoclast differentiation. Cell Death Dis. 2024;15:136. https:\/\/doi.org\/10.1038\/s41419-024-06521-z.","journal-title":"Cell Death Dis"},{"key":"630_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bioactmat.2025.12.048","volume":"60","author":"P Li","year":"2026","unstructured":"Li P, Liang Z, Zeng X, Lei R, Guo S, Zhang Z, et al. Age-related GSS promoter methylation in BMSCs drives osteoporosis and the reversal by targeted GSH delivery. Bioact Mater. 2026;60:472\u201391. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.12.048.","journal-title":"Bioact Mater"},{"key":"630_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41420-024-01925-4","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Xiao H, Liu Z, Liu X, Feng Z, et al. METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging. Cell Death Discov. 2024;10:155. https:\/\/doi.org\/10.1038\/s41420-024-01925-4.","journal-title":"Cell Death Discov"},{"key":"630_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.bioactmat.2026.05.030","volume":"64","author":"D Zhu","year":"2026","unstructured":"Zhu D, Ling S, Fang H, Yang Q, Du Y, Cui W, et al. In vivo circRNA-engineered macrophages mediate localized MMP9 neutralization to rejuvenate aged bone. Bioact Mater. 2026;64:701\u201315. https:\/\/doi.org\/10.1016\/j.bioactmat.2026.05.030.","journal-title":"Bioact Mater"},{"key":"630_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","volume":"19","author":"SJ Hogg","year":"2020","unstructured":"Hogg SJ, Beavis PA, Dawson MA, Johnstone RW. Targeting the epigenetic regulation of antitumour immunity. Nat Rev Drug Discov. 2020;19:776\u2013800. https:\/\/doi.org\/10.1038\/s41573-020-0077-5.","journal-title":"Nat Rev Drug Discov"},{"key":"630_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019;571:489\u201399. https:\/\/doi.org\/10.1038\/s41586-019-1411-0.","journal-title":"Nature"},{"issue":"Suppl","key":"630_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(Suppl):245\u201354. https:\/\/doi.org\/10.1038\/ng1089.","journal-title":"Nat Genet"},{"key":"630_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41576-018-0089-8","volume":"20","author":"SL Klemm","year":"2019","unstructured":"Klemm SL, Shipony Z, Greenleaf WJ. Chromatin accessibility and the regulatory epigenome. Nat Rev Genet. 2019;20:207\u201320. https:\/\/doi.org\/10.1038\/s41576-018-0089-8.","journal-title":"Nat Rev Genet"},{"key":"630_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17:487\u2013500. https:\/\/doi.org\/10.1038\/nrg.2016.59.","journal-title":"Nat Rev Genet"},{"key":"630_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrg.2017.80","volume":"19","author":"F Lyko","year":"2018","unstructured":"Lyko F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat Rev Genet. 2018;19:81\u201392. https:\/\/doi.org\/10.1038\/nrg.2017.80.","journal-title":"Nat Rev Genet"},{"key":"630_CR26","doi-asserted-by":"publisher","DOI":"10.1042\/BST20210725","author":"P Sarkies","year":"2022","unstructured":"Sarkies P. Encyclopaedia of eukaryotic DNA methylation: from patterns to mechanisms and functions. Biochem Soc Trans. 2022;50:1179\u201390. https:\/\/doi.org\/10.1042\/BST20210725.","journal-title":"Biochem Soc Trans"},{"key":"630_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","volume":"38","author":"AL Mattei","year":"2022","unstructured":"Mattei AL, Bailly N, Meissner A. DNA methylation: a historical perspective. Trends Genet. 2022;38:676\u2013707. https:\/\/doi.org\/10.1016\/j.tig.2022.03.010.","journal-title":"Trends Genet"},{"key":"630_CR28","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg MVC, Bourc\u2019his D. The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol. 2019;20:590\u2013607. https:\/\/doi.org\/10.1038\/s41580-019-0159-6.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"630_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature14192","volume":"517","author":"D Sch\u00fcbeler","year":"2015","unstructured":"Sch\u00fcbeler D. Function and information content of DNA methylation. Nature. 2015;517:321\u20136. https:\/\/doi.org\/10.1038\/nature14192.","journal-title":"Nature"},{"key":"630_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrg3354","volume":"14","author":"ZD Smith","year":"2013","unstructured":"Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013;14:204\u201320. https:\/\/doi.org\/10.1038\/nrg3354.","journal-title":"Nat Rev Genet"},{"key":"630_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.biochem.74.010904.153721","volume":"74","author":"MG Goll","year":"2005","unstructured":"Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005;74:481\u2013514. https:\/\/doi.org\/10.1146\/annurev.biochem.74.010904.153721.","journal-title":"Annu Rev Biochem"},{"key":"630_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247\u201357. https:\/\/doi.org\/10.1016\/s0092-8674(00)81656-6.","journal-title":"Cell"},{"key":"630_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107328","volume":"207","author":"T Chen","year":"2024","unstructured":"Chen T, Mahdadi S, Vidal M, Desb\u00e8ne-Finck S. Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy. Pharmacol Res. 2024;207:107328. https:\/\/doi.org\/10.1016\/j.phrs.2024.107328.","journal-title":"Pharmacol Res"},{"key":"630_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/1177271919846454","volume":"14","author":"KK Wong","year":"2019","unstructured":"Wong KK, Lawrie CH, Green TM. Oncogenic roles and inhibitors of DNMT1, DNMT3A, and DNMT3B in acute myeloid leukaemia. Biomark Insights. 2019;14:1177271919846454. https:\/\/doi.org\/10.1177\/1177271919846454.","journal-title":"Biomark Insights"},{"key":"630_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41375-018-0192-z","volume":"33","author":"C Vicente-Due\u00f1as","year":"2019","unstructured":"Vicente-Due\u00f1as C, Gonz\u00e1lez-Herrero I, Sehgal L, Garc\u00eda-Ram\u00edrez I, Rodr\u00edguez-Hern\u00e1ndez G, Pintado B, et al. Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia. Leukemia. 2019;33:249\u201378. https:\/\/doi.org\/10.1038\/s41375-018-0192-z.","journal-title":"Leukemia"},{"key":"630_CR36","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.bbrc.2017.07.137","volume":"491","author":"Y Hu","year":"2017","unstructured":"Hu Y, Ma Z, He Y, Liu W, Su Y, Tang Z. LncRNA-SNHG1 contributes to gastric cancer cell proliferation by regulating DNMT1. Biochem Biophys Res Commun. 2017;491:926\u201331. https:\/\/doi.org\/10.1016\/j.bbrc.2017.07.137.","journal-title":"Biochem Biophys Res Commun"},{"key":"630_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12760","volume":"71","author":"S-C Su","year":"2021","unstructured":"Su S-C, Yeh C-M, Lin C-W, Hsieh Y-H, Chuang C-Y, Tang C-H, et al. A novel melatonin-regulated lncRNA suppresses TPA-induced oral cancer cell motility through replenishing PRUNE2 expression. J Pineal Res. 2021;71:e12760. https:\/\/doi.org\/10.1111\/jpi.12760.","journal-title":"J Pineal Res"},{"key":"630_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2026.104034","volume":"90","author":"Z Zhu","year":"2026","unstructured":"Zhu Z, Wang Y, Yu X, Wang T, Li Y, Wang R, et al. Methylation reader MBD2-mediated GPX4 transcriptional repression drives ovarian granulosa cell ferroptosis in PCOS. Redox Biol. 2026;90:104034. https:\/\/doi.org\/10.1016\/j.redox.2026.104034.","journal-title":"Redox Biol"},{"key":"630_CR39","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1158\/2159-8290.CD-25-0587","volume":"15","author":"C Huang","year":"2025","unstructured":"Huang C, Gao Y, Chen J, Hong JH, Jiang Y, Chai KXY, et al. Priming with DNMT inhibitors potentiates PD-1 immunotherapy by triggering viral mimicry in relapsed\/refractory NK\/T-cell lymphoma. Cancer Discov. 2025;15:2450\u201367. https:\/\/doi.org\/10.1158\/2159-8290.CD-25-0587.","journal-title":"Cancer Discov"},{"key":"630_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12967-019-02145-6","volume":"17","author":"W Wang","year":"2019","unstructured":"Wang W, Chen G, Wang B, Yuan Z, Liu G, Niu B, et al. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation. J Transl Med. 2019;17:421. https:\/\/doi.org\/10.1186\/s12967-019-02145-6.","journal-title":"J Transl Med"},{"key":"630_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/emboj.2012.331","volume":"32","author":"S Kagiwada","year":"2013","unstructured":"Kagiwada S, Kurimoto K, Hirota T, Yamaji M, Saitou M. Replication-coupled passive DNA demethylation for the erasure of genome imprints in mice. EMBO J. 2013;32:340\u201353. https:\/\/doi.org\/10.1038\/emboj.2012.331.","journal-title":"EMBO J"},{"key":"630_CR42","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1242\/dev.093229","volume":"140","author":"R Ohno","year":"2013","unstructured":"Ohno R, Nakayama M, Naruse C, Okashita N, Takano O, Tachibana M, et al. A replication-dependent passive mechanism modulates DNA demethylation in mouse primordial germ cells. Development. 2013;140:2892\u2013903. https:\/\/doi.org\/10.1242\/dev.093229.","journal-title":"Development"},{"key":"630_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13072-018-0228-7","volume":"11","author":"X Wu","year":"2018","unstructured":"Wu X, Li G, Xie R. Decoding the role of TET family dioxygenases in lineage specification. Epigenetics Chromatin. 2018;11:58. https:\/\/doi.org\/10.1186\/s13072-018-0228-7.","journal-title":"Epigenetics Chromatin"},{"key":"630_CR44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nature12805","volume":"504","author":"S Yamaguchi","year":"2013","unstructured":"Yamaguchi S, Shen L, Liu Y, Sendler D, Zhang Y. Role of Tet1 in erasure of genomic imprinting. Nature. 2013;504:460\u20134. https:\/\/doi.org\/10.1038\/nature12805.","journal-title":"Nature"},{"key":"630_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11709","volume":"492","author":"S Yamaguchi","year":"2012","unstructured":"Yamaguchi S, Hong K, Liu R, Shen L, Inoue A, Diep D, et al. Tet1 controls meiosis by regulating meiotic gene expression. Nature. 2012;492:443\u20137. https:\/\/doi.org\/10.1038\/nature11709.","journal-title":"Nature"},{"key":"630_CR46","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1126\/science.1210944","volume":"333","author":"Y-F He","year":"2011","unstructured":"He Y-F, Li B-Z, Li Z, Liu P, Wang Y, Tang Q, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011;333:1303\u20137. https:\/\/doi.org\/10.1126\/science.1210944.","journal-title":"Science"},{"key":"630_CR47","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1242\/dev.129.8.1807","volume":"129","author":"J Lee","year":"2002","unstructured":"Lee J, Inoue K, Ono R, Ogonuki N, Kohda T, Kaneko-Ishino T, et al. Erasing genomic imprinting memory in mouse clone embryos produced from day 11.5 primordial germ cells. Development. 2002;129:1807\u201317. https:\/\/doi.org\/10.1242\/dev.129.8.1807.","journal-title":"Development"},{"key":"630_CR48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ygeno.2014.08.012","volume":"104","author":"PWS Hill","year":"2014","unstructured":"Hill PWS, Amouroux R, Hajkova P. DNA demethylation, Tet proteins and 5-hydroxymethylcytosine in epigenetic reprogramming: an emerging complex story. Genomics. 2014;104:324\u201333. https:\/\/doi.org\/10.1016\/j.ygeno.2014.08.012.","journal-title":"Genomics"},{"key":"630_CR49","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.184.4139.868","volume":"184","author":"RD Kornberg","year":"1974","unstructured":"Kornberg RD. Chromatin structure: a repeating unit of histones and DNA. Science. 1974;184:868\u201371. https:\/\/doi.org\/10.1126\/science.184.4139.868.","journal-title":"Science"},{"key":"630_CR50","doi-asserted-by":"publisher","unstructured":"Luger K, M\u00e4der AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997;389:251\u201360. https:\/\/doi.org\/10.1038\/38444.","DOI":"10.1038\/38444"},{"key":"630_CR51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693\u2013705. https:\/\/doi.org\/10.1016\/j.cell.2007.02.005.","journal-title":"Cell"},{"key":"630_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381\u201395. https:\/\/doi.org\/10.1038\/cr.2011.22.","journal-title":"Cell Res"},{"key":"630_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.semcdb.2022.11.002","volume":"154","author":"G Sharma","year":"2024","unstructured":"Sharma G, Sultana A, Abdullah KM, Pothuraju R, Nasser MW, Batra SK, et al. Epigenetic regulation of bone remodeling and bone metastasis. Semin Cell Dev Biol. 2024;154:275\u201385. https:\/\/doi.org\/10.1016\/j.semcdb.2022.11.002.","journal-title":"Semin Cell Dev Biol"},{"key":"630_CR54","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/35044127","volume":"408","author":"M Vogelauer","year":"2000","unstructured":"Vogelauer M, Wu J, Suka N, Grunstein M. Global histone acetylation and deacetylation in yeast. Nature. 2000;408:495\u20138. https:\/\/doi.org\/10.1038\/35044127.","journal-title":"Nature"},{"key":"630_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13148-018-0583-z","volume":"10","author":"E Orouji","year":"2018","unstructured":"Orouji E, Utikal J. Tackling malignant melanoma epigenetically: histone lysine methylation. Clin Epigenetics. 2018;10:145. https:\/\/doi.org\/10.1186\/s13148-018-0583-z.","journal-title":"Clin Epigenetics"},{"key":"630_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13148-020-00941-2","volume":"12","author":"D Komar","year":"2020","unstructured":"Komar D, Juszczynski P. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy. Clin Epigenetics. 2020;12:147. https:\/\/doi.org\/10.1186\/s13148-020-00941-2.","journal-title":"Clin Epigenetics"},{"key":"630_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.964103","volume":"13","author":"P Sun","year":"2022","unstructured":"Sun P, Huang T, Huang C, Wang Y, Tang D. Role of histone modification in the occurrence and development of osteoporosis. Front Endocrinol (Lausanne). 2022;13:964103. https:\/\/doi.org\/10.3389\/fendo.2022.964103.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"630_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/procel\/pwac032","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Ge K, Li T, Cai R, Chen Y. The engagement of histone lysine methyltransferases with nucleosomes: structural basis, regulatory mechanisms, and therapeutic implications. Protein Cell. 2023;14:165\u201379. https:\/\/doi.org\/10.1093\/procel\/pwac032.","journal-title":"Protein Cell"},{"key":"630_CR59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","volume":"48","author":"JC Black","year":"2012","unstructured":"Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell. 2012;48:491\u2013507. https:\/\/doi.org\/10.1016\/j.molcel.2012.11.006.","journal-title":"Mol Cell"},{"key":"630_CR60","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41580-019-0151-1","volume":"20","author":"A Jambhekar","year":"2019","unstructured":"Jambhekar A, Dhall A, Shi Y. Roles and regulation of histone methylation in animal development. Nat Rev Mol Cell Biol. 2019;20:625\u201341. https:\/\/doi.org\/10.1038\/s41580-019-0151-1.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"630_CR61","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s12276-025-01561-7","volume":"57","author":"Y Cho","year":"2025","unstructured":"Cho Y, Kim YK. Multifaceted roles of CARM1 beyond histone arginine methylation. Exp Mol Med. 2025;57:2251\u201363. https:\/\/doi.org\/10.1038\/s12276-025-01561-7.","journal-title":"Exp Mol Med"},{"key":"630_CR62","doi-asserted-by":"publisher","first-page":"10364","DOI":"10.1093\/nar\/gkad754","volume":"51","author":"T Oishi","year":"2023","unstructured":"Oishi T, Hatazawa S, Kujirai T, Kato J, Kobayashi Y, Ogasawara M, et al. Contributions of histone tail clipping and acetylation in nucleosome transcription by RNA polymerase II. Nucleic Acids Res. 2023;51:10364\u201374. https:\/\/doi.org\/10.1093\/nar\/gkad754.","journal-title":"Nucleic Acids Res"},{"key":"630_CR63","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025064","volume":"7","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Garcia BA. Comprehensive catalog of currently documented histone modifications. Cold Spring Harb Perspect Biol. 2015;7:a025064. https:\/\/doi.org\/10.1101\/cshperspect.a025064.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"630_CR64","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova M, Akhtar A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat Rev Mol Cell Biol. 2022;23:329\u201349. https:\/\/doi.org\/10.1038\/s41580-021-00441-y.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"630_CR65","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-100617-062802","volume":"34","author":"E Oh","year":"2018","unstructured":"Oh E, Akopian D, Rape M. Principles of ubiquitin-dependent signaling. Annu Rev Cell Dev Biol. 2018;34:137\u201362. https:\/\/doi.org\/10.1146\/annurev-cellbio-100617-062802.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"630_CR66","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tig.2020.12.005","volume":"37","author":"F Mattiroli","year":"2021","unstructured":"Mattiroli F, Penengo L. Histone ubiquitination: an integrative signaling platform in genome stability. Trends Genet. 2021;37:566\u201381. https:\/\/doi.org\/10.1016\/j.tig.2020.12.005.","journal-title":"Trends Genet"},{"key":"630_CR67","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.molcel.2008.02.014","volume":"29","author":"VM Weake","year":"2008","unstructured":"Weake VM, Workman JL. Histone ubiquitination: triggering gene activity. Mol Cell. 2008;29:653\u201363. https:\/\/doi.org\/10.1016\/j.molcel.2008.02.014.","journal-title":"Mol Cell"},{"key":"630_CR68","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","volume":"9","author":"W Yao","year":"2024","unstructured":"Yao W, Hu X, Wang X. Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases. Signal Transduct Target Ther. 2024;9:232. https:\/\/doi.org\/10.1038\/s41392-024-01918-w.","journal-title":"Signal Transduct Target Ther"},{"key":"630_CR69","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361:1346\u20139. https:\/\/doi.org\/10.1126\/science.aau1646.","journal-title":"Science"},{"key":"630_CR70","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-052521-035330","volume":"92","author":"MN Flamand","year":"2023","unstructured":"Flamand MN, Tegowski M, Meyer KD. The proteins of mRNA modification: writers, readers, and erasers. Annu Rev Biochem. 2023;92:145\u201373. https:\/\/doi.org\/10.1146\/annurev-biochem-052521-035330.","journal-title":"Annu Rev Biochem"},{"key":"630_CR71","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.7150\/ijbs.104460","volume":"21","author":"Z Li","year":"2025","unstructured":"Li Z, Meng K, Lan S, Ren Z, Lai Z, Ao X, et al. The role of mRNA modifications in bone diseases. Int J Biol Sci. 2025;21:1065\u201380. https:\/\/doi.org\/10.7150\/ijbs.104460.","journal-title":"Int J Biol Sci"},{"key":"630_CR72","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.gendis.2023.01.032","volume":"11","author":"Y Gu","year":"2024","unstructured":"Gu Y, Song Y, Pan Y, Liu J. The essential roles of m6A modification in osteogenesis and common bone diseases. Genes Dis. 2024;11:335\u201345. https:\/\/doi.org\/10.1016\/j.gendis.2023.01.032.","journal-title":"Genes Dis"},{"key":"630_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101728","volume":"5","author":"Y Zou","year":"2024","unstructured":"Zou Y, Guo S, Wen L, Lv D, Tu J, Liao Y, et al. Targeting NAT10 inhibits osteosarcoma progression via ATF4\/ASNS-mediated asparagine biosynthesis. Cell Rep Med. 2024;5:101728. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101728.","journal-title":"Cell Rep Med"},{"key":"630_CR74","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172345","volume":"9","author":"Y-J Li","year":"2024","unstructured":"Li Y-J, Guo Q, Ye M-S, Cai G, Xiao W-F, Deng S, et al. YBX1 promotes type H vessel-dependent bone formation in an m5C-dependent manner. JCI Insight. 2024;9:e172345. https:\/\/doi.org\/10.1172\/jci.insight.172345.","journal-title":"JCI Insight"},{"key":"630_CR75","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201\u20136. https:\/\/doi.org\/10.1038\/nature11112.","journal-title":"Nature"},{"key":"630_CR76","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169:1187\u2013200. https:\/\/doi.org\/10.1016\/j.cell.2017.05.045.","journal-title":"Cell"},{"key":"630_CR77","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"X-L Ping","year":"2014","unstructured":"Ping X-L, Sun B-F, Wang L, Xiao W, Yang X, Wang W-J, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24:177\u201389. https:\/\/doi.org\/10.1038\/cr.2014.3.","journal-title":"Cell Res"},{"key":"630_CR78","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","volume":"33","author":"KD Meyer","year":"2017","unstructured":"Meyer KD, Jaffrey SR. Rethinking m6A readers, writers, and erasers. Annu Rev Cell Dev Biol. 2017;33:319\u201342. https:\/\/doi.org\/10.1146\/annurev-cellbio-100616-060758.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"630_CR79","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608\u201324. https:\/\/doi.org\/10.1038\/s41580-019-0168-5.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"630_CR80","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell. 2018;175:1872-1886.e24. https:\/\/doi.org\/10.1016\/j.cell.2018.10.030.","journal-title":"Cell"},{"key":"630_CR81","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-025-00286-3","volume":"6","author":"L Jiao","year":"2025","unstructured":"Jiao L, Si Y, Yuan Y, Lei X, Jiang Q, Yang L, et al. Emerging role of N-acetyltransferase 10 in diseases: RNA ac4C modification and beyond. Mol Biomed. 2025;6:46. https:\/\/doi.org\/10.1186\/s43556-025-00286-3.","journal-title":"Mol Biomed"},{"key":"630_CR82","doi-asserted-by":"publisher","unstructured":"Wan K, Nie T, Ouyang W, Xiong Y, Bian J, Huang Y, et al. Exploring the impact of N4-acetylcytidine modification in RNA on non-neoplastic disease: unveiling its role in pathogenesis and therapeutic opportunities. Brief Funct Genomics. 2025;24:elae020. https:\/\/doi.org\/10.1093\/bfgp\/elae020.","DOI":"10.1093\/bfgp\/elae020"},{"key":"630_CR83","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.molcel.2022.05.016","volume":"82","author":"D Arango","year":"2022","unstructured":"Arango D, Sturgill D, Yang R, Kanai T, Bauer P, Roy J, et al. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Mol Cell. 2022;82:2797-2814.e11. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.016.","journal-title":"Mol Cell"},{"key":"630_CR84","doi-asserted-by":"publisher","first-page":"1623276","DOI":"10.3389\/fcell.2025.1623276","volume":"13","author":"D Qin","year":"2025","unstructured":"Qin D, Liu Q, Ma X, Wang R, Lu T, Yang Y, et al. Research progress on NAT10-mediated acetylation in normal development and disease. Front Cell Dev Biol. 2025;13:1623276. https:\/\/doi.org\/10.3389\/fcell.2025.1623276.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"630_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70734","volume":"2026","author":"S Xiao","year":"2020","unstructured":"Xiao S, Xiang T, Yang C, Wang X, Huang G, Luo F, et al. RNA modifications: current understandings and future perspectives. MedComm. 2020;2026(7):e70734. https:\/\/doi.org\/10.1002\/mco2.70734.","journal-title":"MedComm"},{"key":"630_CR86","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/humupd\/dmaf005","volume":"31","author":"Y Xiang","year":"2025","unstructured":"Xiang Y, Chang H-M, Leung PCK, Bai L, Zhu Y. RNA modifications in female reproductive physiology and disease: emerging roles and clinical implications. Hum Reprod Update. 2025;31:333\u201360. https:\/\/doi.org\/10.1093\/humupd\/dmaf005.","journal-title":"Hum Reprod Update"},{"key":"630_CR87","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2021","unstructured":"Wiener D, Schwartz S. The epitranscriptome beyond m6A. Nat Rev Genet. 2021;22:119\u201331. https:\/\/doi.org\/10.1038\/s41576-020-00295-8.","journal-title":"Nat Rev Genet"},{"key":"630_CR88","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1093\/nar\/gks144","volume":"40","author":"JE Squires","year":"2012","unstructured":"Squires JE, Patel HR, Nousch M, Sibbritt T, Humphreys DT, Parker BJ, et al. Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 2012;40:5023\u201333. https:\/\/doi.org\/10.1093\/nar\/gks144.","journal-title":"Nucleic Acids Res"},{"key":"630_CR89","doi-asserted-by":"publisher","first-page":"11582","DOI":"10.1021\/ja505305z","volume":"136","author":"L Fu","year":"2014","unstructured":"Fu L, Guerrero CR, Zhong N, Amato NJ, Liu Y, Liu S, et al. Tet-mediated formation of 5-hydroxymethylcytosine in RNA. J Am Chem Soc. 2014;136:11582\u20135. https:\/\/doi.org\/10.1021\/ja505305z.","journal-title":"J Am Chem Soc"},{"key":"630_CR90","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/cr.2017.55","volume":"27","author":"X Yang","year":"2017","unstructured":"Yang X, Yang Y, Sun B-F, Chen Y-S, Xu J-W, Lai W-Y, et al. 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m5C reader. Cell Res. 2017;27:606\u201325. https:\/\/doi.org\/10.1038\/cr.2017.55.","journal-title":"Cell Res"},{"key":"630_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01263-w","volume":"20","author":"P Nombela","year":"2021","unstructured":"Nombela P, Miguel-L\u00f3pez B, Blanco S. The role of m6A, m5C and \u03a8 RNA modifications in cancer: novel therapeutic opportunities. Mol Cancer. 2021;20:18. https:\/\/doi.org\/10.1186\/s12943-020-01263-w.","journal-title":"Mol Cancer"},{"key":"630_CR92","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861\u201374. https:\/\/doi.org\/10.1038\/nrg3074.","journal-title":"Nat Rev Genet"},{"key":"630_CR93","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.tem.2023.02.007","volume":"34","author":"K Xu","year":"2023","unstructured":"Xu K, Xia P, Chen X, Ma W, Yuan Y. ncRNA-mediated fatty acid metabolism reprogramming in HCC. Trends Endocrinol Metab. 2023;34:278\u201391. https:\/\/doi.org\/10.1016\/j.tem.2023.02.007.","journal-title":"Trends Endocrinol Metab"},{"key":"630_CR94","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179:1033\u201355. https:\/\/doi.org\/10.1016\/j.cell.2019.10.017.","journal-title":"Cell"},{"key":"630_CR95","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","volume":"79","author":"MR Fabian","year":"2010","unstructured":"Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351\u201379. https:\/\/doi.org\/10.1146\/annurev-biochem-060308-103103.","journal-title":"Annu Rev Biochem"},{"key":"630_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031500","volume":"23","author":"L Oton-Gonzalez","year":"2022","unstructured":"Oton-Gonzalez L, Mazziotta C, Iaquinta MR, Mazzoni E, Nocini R, Trevisiol L, et al. Genetics and epigenetics of bone remodeling and metabolic bone diseases. Int J Mol Sci. 2022;23:1500. https:\/\/doi.org\/10.3390\/ijms23031500.","journal-title":"Int J Mol Sci"},{"key":"630_CR97","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/cancers12051245","volume":"12","author":"X-Z Zhang","year":"2020","unstructured":"Zhang X-Z, Liu H, Chen S-R. Mechanisms of long non-coding RNAs in cancers and their dynamic regulations. Cancers (Basel). 2020;12:1245. https:\/\/doi.org\/10.3390\/cancers12051245.","journal-title":"Cancers (Basel)"},{"key":"630_CR98","doi-asserted-by":"publisher","first-page":"11464","DOI":"10.3390\/ijms222111464","volume":"22","author":"JC Rotondo","year":"2021","unstructured":"Rotondo JC, Mazziotta C, Lanzillotti C, Tognon M, Martini F. Epigenetic dysregulations in merkel cell polyomavirus-driven merkel cell carcinoma. Int J Mol Sci. 2021;22:11464. https:\/\/doi.org\/10.3390\/ijms222111464.","journal-title":"Int J Mol Sci"},{"key":"630_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114672","volume":"162","author":"B Ma","year":"2023","unstructured":"Ma B, Wang S, Wu W, Shan P, Chen Y, Meng J, et al. Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research. Biomed Pharmacother. 2023;162:114672. https:\/\/doi.org\/10.1016\/j.biopha.2023.114672.","journal-title":"Biomed Pharmacother"},{"key":"630_CR100","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07540","volume":"4","author":"SP Barrett","year":"2015","unstructured":"Barrett SP, Wang PL, Salzman J. Circular RNA biogenesis can proceed through an exon-containing lariat precursor. Elife. 2015;4:e07540. https:\/\/doi.org\/10.7554\/eLife.07540.","journal-title":"Elife"},{"key":"630_CR101","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391. https:\/\/doi.org\/10.1038\/s41576-019-0158-7.","journal-title":"Nat Rev Genet"},{"key":"630_CR102","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-022-01582-0","volume":"21","author":"C Xue","year":"2022","unstructured":"Xue C, Li G, Zheng Q, Gu X, Bao Z, Lu J, et al. The functional roles of the circRNA\/Wnt axis in cancer. Mol Cancer. 2022;21:108. https:\/\/doi.org\/10.1186\/s12943-022-01582-0.","journal-title":"Mol Cancer"},{"key":"630_CR103","first-page":"1167","volume":"6","author":"F Wang","year":"2016","unstructured":"Wang F, Nazarali AJ, Ji S. Circular RNAs as potential biomarkers for cancer diagnosis and therapy. Am J Cancer Res. 2016;6:1167\u201376.","journal-title":"Am J Cancer Res"},{"key":"630_CR104","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141\u201357. https:\/\/doi.org\/10.1261\/rna.035667.112.","journal-title":"RNA"},{"key":"630_CR105","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","volume":"16","author":"S Meng","year":"2017","unstructured":"Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16:94. https:\/\/doi.org\/10.1186\/s12943-017-0663-2.","journal-title":"Mol Cancer"},{"key":"630_CR106","doi-asserted-by":"publisher","DOI":"10.1242\/bio.058534","volume":"11","author":"C Tao","year":"2022","unstructured":"Tao C, Liu J, Li Z, Lai P, Zhang S, Qu J, et al. DNMT1 is a negative regulator of osteogenesis. Biol Open. 2022;11:bio058534. https:\/\/doi.org\/10.1242\/bio.058534.","journal-title":"Biol Open"},{"key":"630_CR107","doi-asserted-by":"publisher","first-page":"C429","DOI":"10.1152\/ajpcell.00334.2023","volume":"326","author":"L Tang","year":"2024","unstructured":"Tang L, Zhang Y-Y, Liu W-J, Fu Q, Zhao J, Liu Y-B. DNA methylation of promoter region inhibits galectin-1 expression in BMSCs of aged mice. Am J Physiol Cell Physiol. 2024;326:C429\u201341. https:\/\/doi.org\/10.1152\/ajpcell.00334.2023.","journal-title":"Am J Physiol Cell Physiol"},{"key":"630_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404518","volume":"11","author":"J Zhao","year":"2024","unstructured":"Zhao J, Chen A, Wang R, Qiu D, Chen H, Li J, et al. Bmi-1 epigenetically orchestrates osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cells to delay bone aging. Adv Sci (Weinh). 2024;11:e2404518. https:\/\/doi.org\/10.1002\/advs.202404518.","journal-title":"Adv Sci (Weinh)"},{"key":"630_CR109","doi-asserted-by":"publisher","first-page":"5596","DOI":"10.1038\/s41467-020-19360-1","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Deng P, Liu Y, Wu Y, Chen Y, Guo Y, et al. Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations. Nat Commun. 2020;11:5596. https:\/\/doi.org\/10.1038\/s41467-020-19360-1.","journal-title":"Nat Commun"},{"key":"630_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13551","volume":"21","author":"M Hu","year":"2022","unstructured":"Hu M, Xing L, Zhang L, Liu F, Wang S, Xie Y, et al. NAP1L2 drives mesenchymal stem cell senescence and suppresses osteogenic differentiation. Aging Cell. 2022;21:e13551. https:\/\/doi.org\/10.1111\/acel.13551.","journal-title":"Aging Cell"},{"key":"630_CR111","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s13287-021-02545-w","volume":"12","author":"C Ma","year":"2021","unstructured":"Ma C, Gao J, Liang J, Dai W, Wang Z, Xia M, et al. HDAC6 inactivates Runx2 promoter to block osteogenesis of bone marrow stromal cells in age-related bone loss of mice. Stem Cell Res Ther. 2021;12:484. https:\/\/doi.org\/10.1186\/s13287-021-02545-w.","journal-title":"Stem Cell Res Ther"},{"key":"630_CR112","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s43587-021-00105-8","volume":"1","author":"A Pouikli","year":"2021","unstructured":"Pouikli A, Parekh S, Maleszewska M, Nikopoulou C, Baghdadi M, Tripodi I, et al. Chromatin remodeling due to degradation of citrate carrier impairs osteogenesis of aged mesenchymal stem cells. Nat Aging. 2021;1:810\u201325. https:\/\/doi.org\/10.1038\/s43587-021-00105-8.","journal-title":"Nat Aging"},{"key":"630_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167273","volume":"1870","author":"X-W Liu","year":"2024","unstructured":"Liu X-W, Xu H-W, Yi Y-Y, Zhang S-B, Chang S-J, Pan W, et al. Inhibition of Mettl3 ameliorates osteoblastic senescence by mitigating m6A modifications on Slc1a5 via Igf2bp2-dependent mechanisms. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167273. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167273.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"630_CR114","doi-asserted-by":"publisher","first-page":"23461","DOI":"10.1038\/s41598-024-75033-9","volume":"14","author":"Y Huang","year":"2024","unstructured":"Huang Y, Wang S, Hu D, Zhang L, Shi S. ALKBH5 regulates etoposide-induced cellular senescence and osteogenic differentiation in osteoporosis through mediating the m6A modification of VDAC3. Sci Rep. 2024;14:23461. https:\/\/doi.org\/10.1038\/s41598-024-75033-9.","journal-title":"Sci Rep"},{"key":"630_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111672","volume":"420","author":"Y Chen","year":"2025","unstructured":"Chen Y, Wang Y, Xiao H, Teng F, Yang A, Liu J, et al. METTL3-mediated modification of SIRT1 m6A methylation protects osteoblasts from TBHP-induced senescence and promotes osteoblast proliferation. Chem Biol Interact. 2025;420:111672. https:\/\/doi.org\/10.1016\/j.cbi.2025.111672.","journal-title":"Chem Biol Interact"},{"key":"630_CR116","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/acel.12484","volume":"15","author":"S Weilner","year":"2016","unstructured":"Weilner S, Schraml E, Wieser M, Messner P, Schneider K, Wassermann K, et al. Secreted microvesicular miR-31 inhibits osteogenic differentiation of mesenchymal stem cells. Aging Cell. 2016;15:744\u201354. https:\/\/doi.org\/10.1111\/acel.12484.","journal-title":"Aging Cell"},{"key":"630_CR117","doi-asserted-by":"publisher","first-page":"10872","DOI":"10.1038\/ncomms10872","volume":"7","author":"D Li","year":"2016","unstructured":"Li D, Liu J, Guo B, Liang C, Dang L, Lu C, et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun. 2016;7:10872. https:\/\/doi.org\/10.1038\/ncomms10872.","journal-title":"Nat Commun"},{"key":"630_CR118","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41418-021-00858-0","volume":"29","author":"H Zhang","year":"2022","unstructured":"Zhang H, Xu R, Li B, Xin Z, Ling Z, Zhu W, et al. LncRNA NEAT1 controls the lineage fates of BMSCs during skeletal aging by impairing mitochondrial function and pluripotency maintenance. Cell Death Differ. 2022;29:351\u201365. https:\/\/doi.org\/10.1038\/s41418-021-00858-0.","journal-title":"Cell Death Differ"},{"key":"630_CR119","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41413-023-00289-2","volume":"11","author":"Y Li","year":"2023","unstructured":"Li Y, Sun W, Li J, Du R, Xing W, Yuan X, et al. HuR-mediated nucleocytoplasmic translocation of HOTAIR relieves its inhibition of osteogenic differentiation and promotes bone formation. Bone Res. 2023;11:53. https:\/\/doi.org\/10.1038\/s41413-023-00289-2.","journal-title":"Bone Res"},{"key":"630_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ars.2020.8200","volume":"35","author":"L Li","year":"2021","unstructured":"Li L, Wang H, Chen X, Li X, Wang G, Jie Z, et al. Oxidative stress-induced hypermethylation of KLF5 promoter mediated by DNMT3B impairs osteogenesis by diminishing the interaction with \u03b2-catenin. Antioxid Redox Signal. 2021;35:1\u201320. https:\/\/doi.org\/10.1089\/ars.2020.8200.","journal-title":"Antioxid Redox Signal"},{"key":"630_CR121","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/s41467-018-04464-6","volume":"9","author":"R Yang","year":"2018","unstructured":"Yang R, Yu T, Kou X, Gao X, Chen C, Liu D, et al. Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter. Nat Commun. 2018;9:2143. https:\/\/doi.org\/10.1038\/s41467-018-04464-6.","journal-title":"Nat Commun"},{"key":"630_CR122","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41413-024-00365-1","volume":"12","author":"B Ruan","year":"2024","unstructured":"Ruan B, Dong J, Wei F, Huang Z, Yang B, Zhang L, et al. DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis. Bone Res. 2024;12:68. https:\/\/doi.org\/10.1038\/s41413-024-00365-1.","journal-title":"Bone Res"},{"key":"630_CR123","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1080\/15548627.2022.2048432","volume":"18","author":"C Yang","year":"2022","unstructured":"Yang C, Tao H, Zhang H, Xia Y, Bai J, Ge G, et al. TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss. Autophagy. 2022;18:2817\u201329. https:\/\/doi.org\/10.1080\/15548627.2022.2048432.","journal-title":"Autophagy"},{"key":"630_CR124","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41420-024-01835-5","volume":"10","author":"W Da","year":"2024","unstructured":"Da W, Jiang W, Tao L. ROS\/MMP-9 mediated CS degradation in BMSC inhibits citric acid metabolism participating in the dual regulation of bone remodelling. Cell Death Discov. 2024;10:77. https:\/\/doi.org\/10.1038\/s41420-024-01835-5.","journal-title":"Cell Death Discov"},{"key":"630_CR125","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2025.09.023","volume":"241","author":"Y Gu","year":"2025","unstructured":"Gu Y, Wang Z, Wang K, Wang Y, Li Y, Jiang S, et al. Low-dose valproic acid ameliorates osteoporosis by restoring redox homeostasis and suppressing ferritinophagy-dependent ferroptosis via EZH2\/H3K27me3 signaling. Free Radic Biol Med. 2025;241:76\u201389. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.09.023.","journal-title":"Free Radic Biol Med"},{"key":"630_CR126","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s10020-025-01098-5","volume":"31","author":"Z Li","year":"2025","unstructured":"Li Z, Zhang J, Xu T, Hao Z, Li Y. Mechanism of histone demethylase KDM5A in osteoporotic fracture healing through epigenetic regulation of the miR-495\/SKP2\/Runx2 axis. Mol Med. 2025;31:65. https:\/\/doi.org\/10.1186\/s10020-025-01098-5.","journal-title":"Mol Med"},{"key":"630_CR127","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41419-022-05362-y","volume":"13","author":"C Huang","year":"2022","unstructured":"Huang C, Wang Y. Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1. Cell Death Dis. 2022;13:919. https:\/\/doi.org\/10.1038\/s41419-022-05362-y.","journal-title":"Cell Death Dis"},{"key":"630_CR128","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2423991122","volume":"122","author":"X Mo","year":"2025","unstructured":"Mo X, Meng K, Xu B, Li Z, Lan S, Ren Z, et al. Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to exacerbate osteoclastogenesis in postmenopausal osteoporosis. Proc Natl Acad Sci U S A. 2025;122:e2423991122. https:\/\/doi.org\/10.1073\/pnas.2423991122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"630_CR129","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.omtn.2021.06.022","volume":"26","author":"W Yang","year":"2021","unstructured":"Yang W, Li HY, Wu YF, Mi RJ, Liu WZ, Shen X, et al. Ac4C acetylation of RUNX2 catalyzed by NAT10 spurs osteogenesis of BMSCs and prevents ovariectomy-induced bone loss. Mol Ther Nucleic Acids. 2021;26:135\u201347. https:\/\/doi.org\/10.1016\/j.omtn.2021.06.022.","journal-title":"Mol Ther Nucleic Acids"},{"key":"630_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11046-2","volume":"15","author":"Z Deng","year":"2025","unstructured":"Deng Z, Zhong W. CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation via NSUN5-mediated m5C modification. Sci Rep. 2025;15:25246. https:\/\/doi.org\/10.1038\/s41598-025-11046-2.","journal-title":"Sci Rep"},{"key":"630_CR131","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.biopha.2017.02.090","volume":"89","author":"Q Wang","year":"2017","unstructured":"Wang Q, Li Y, Zhang Y, Ma L, Lin L, Meng J, et al. LncRNA MEG3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR-133a-3p. Biomed Pharmacother. 2017;89:1178\u201386. https:\/\/doi.org\/10.1016\/j.biopha.2017.02.090.","journal-title":"Biomed Pharmacother"},{"key":"630_CR132","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.1002\/jcp.26430","volume":"233","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhu Y, Zhang C, Liu J, Sun T, Li D, et al. MiR-542-3p prevents ovariectomy-induced osteoporosis in rats via targeting SFRP1. J Cell Physiol. 2018;233:6798\u2013806. https:\/\/doi.org\/10.1002\/jcp.26430.","journal-title":"J Cell Physiol"},{"key":"630_CR133","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41420-023-01422-0","volume":"9","author":"X Huang","year":"2023","unstructured":"Huang X, Jie S, Li W, Liu C. GATA4-activated lncRNA MALAT1 promotes osteogenic differentiation through inhibiting NEDD4-mediated RUNX1 degradation. Cell Death Discov. 2023;9:150. https:\/\/doi.org\/10.1038\/s41420-023-01422-0.","journal-title":"Cell Death Discov"},{"key":"630_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109844","volume":"116","author":"P Yin","year":"2023","unstructured":"Yin P, Xue Y. CircRNA hsa_circ_0006859 inhibits the osteogenic differentiation of BMSCs and aggravates osteoporosis by targeting miR-642b-5p\/miR-483-3p and upregulating EFNA2\/DOCK3. Int Immunopharmacol. 2023;116:109844. https:\/\/doi.org\/10.1016\/j.intimp.2023.109844.","journal-title":"Int Immunopharmacol"},{"key":"630_CR135","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/jcmm.16982","volume":"26","author":"X Yu","year":"2022","unstructured":"Yu X, Song M-S, Rong P-Z, Chen X-J, Shi L, Wang C-H, et al. LncRNA SNHG1 modulates adipogenic differentiation of BMSCs by promoting DNMT1 mediated Opg hypermethylation via interacting with PTBP1. J Cell Mol Med. 2022;26:60\u201374. https:\/\/doi.org\/10.1111\/jcmm.16982.","journal-title":"J Cell Mol Med"},{"key":"630_CR136","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s12276-020-0475-0","volume":"52","author":"C-G Wang","year":"2020","unstructured":"Wang C-G, Hu Y-H, Su S-L, Zhong D. LncRNA DANCR and miR-320a suppressed osteogenic differentiation in osteoporosis by directly inhibiting the Wnt\/\u03b2-catenin signaling pathway. Exp Mol Med. 2020;52:1310\u201325. https:\/\/doi.org\/10.1038\/s12276-020-0475-0.","journal-title":"Exp Mol Med"},{"key":"630_CR137","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10495-023-01820-w","volume":"28","author":"C Song","year":"2023","unstructured":"Song C, Guo Y, Chen F, Liu W. IRF-1-inhibited lncRNA XIST regulated the osteogenic differentiation via miR-450b\/FBXW7 axis. Apoptosis. 2023;28:669\u201380. https:\/\/doi.org\/10.1007\/s10495-023-01820-w.","journal-title":"Apoptosis"},{"key":"630_CR138","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14838","volume":"11","author":"W Cao","year":"2023","unstructured":"Cao W, Yang X, Hu XH, Li J, Tian J, OuYang R, et al. MiR-344d-3p regulates osteogenic and adipogenic differentiation of mouse mandibular bone marrow mesenchymal stem cells. PeerJ. 2023;11:e14838. https:\/\/doi.org\/10.7717\/peerj.14838.","journal-title":"PeerJ"},{"key":"630_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.348","volume":"4","author":"J Li","year":"2013","unstructured":"Li J, Zhang N, Huang X, Xu J, Fernandes JC, Dai K, et al. Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C\/EBPalpha promoter methylation. Cell Death Dis. 2013;4:e832. https:\/\/doi.org\/10.1038\/cddis.2013.348.","journal-title":"Cell Death Dis"},{"key":"630_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2018.11.003","volume":"363","author":"Y Wen","year":"2019","unstructured":"Wen Y, Shangguan Y, Pan Z, Hu H, Magdalou J, Chen L, et al. Activation of local bone RAS by maternal excessive glucocorticoid participated in the fetal programing of adult osteopenia induced by prenatal caffeine exposure. Toxicol Appl Pharmacol. 2019;363:1\u201310. https:\/\/doi.org\/10.1016\/j.taap.2018.11.003.","journal-title":"Toxicol Appl Pharmacol"},{"key":"630_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115264","volume":"206","author":"Y Shangguan","year":"2022","unstructured":"Shangguan Y, Li X, Qin J, Wen Y, Wang H, Chen L. Positive programming of the GC-IGF1 axis mediates adult osteoporosis susceptibility in male offspring rats induced by prenatal dexamethasone exposure. Biochem Pharmacol. 2022;206:115264. https:\/\/doi.org\/10.1016\/j.bcp.2022.115264.","journal-title":"Biochem Pharmacol"},{"key":"630_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105990","volume":"175","author":"Z Wu","year":"2022","unstructured":"Wu Z, Wen Y, Xiao H, Zhu J, Li B, Shangguan Y, et al. 11\u03b2-Hydroxysteroid dehydrogenase 2: a key mediator of high susceptibility to osteoporosis in offspring after prenatal dexamethasone exposure. Pharmacol Res. 2022;175:105990. https:\/\/doi.org\/10.1016\/j.phrs.2021.105990.","journal-title":"Pharmacol Res"},{"key":"630_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.133997","volume":"469","author":"Z-Y Du","year":"2024","unstructured":"Du Z-Y, Zhu H-L, Chang W, Zhang Y-F, Ling Q, Wang K-W, et al. Maternal prednisone exposure during pregnancy elevates susceptibility to osteoporosis in female offspring: the role of mitophagy\/FNDC5 alteration in skeletal muscle. J Hazard Mater. 2024;469:133997. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.133997.","journal-title":"J Hazard Mater"},{"key":"630_CR144","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.bbrc.2019.06.073","volume":"516","author":"C-Y Zhu","year":"2019","unstructured":"Zhu C-Y, Yao C, Zhu L-Q, She C, Zhou X-Z. Dexamethasone-induced cytotoxicity in human osteoblasts is associated with circular RNA HIPK3 downregulation. Biochem Biophys Res Commun. 2019;516:645\u201352. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.073.","journal-title":"Biochem Biophys Res Commun"},{"key":"630_CR145","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-25-0218","volume":"268","author":"J Li","year":"2026","unstructured":"Li J, Fu Q, Kang L, Gao Y, Shi J. OIP5-AS1\/miR-335-5p regulates osteoblast proliferation and injury in glucocorticoid-induced osteoporosis in male mice. J Endocrinol. 2026;268:e250218. https:\/\/doi.org\/10.1530\/JOE-25-0218.","journal-title":"J Endocrinol"},{"key":"630_CR146","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3724\/abbs.2025014","volume":"57","author":"H Yang","year":"2025","unstructured":"Yang H, Ding N, Qing S, Hao Y, Zhao C, Wu K, et al. Knockdown of lncRNA XR_877193.1 suppresses ferroptosis and promotes osteogenic differentiation via the PI3K\/AKT signaling pathway in SONFH. Acta Biochim Biophys Sin (Shanghai). 2025;57:1350\u201362. https:\/\/doi.org\/10.3724\/abbs.2025014.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"630_CR147","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1080\/13880209.2022.2093385","volume":"60","author":"P Wu","year":"2022","unstructured":"Wu P, Jiao F, Huang H, Liu D, Tang W, Liang J, et al. Morinda officinalis polysaccharide enable suppression of osteoclastic differentiation by exosomes derived from rat mesenchymal stem cells. Pharm Biol. 2022;60:1303\u201316. https:\/\/doi.org\/10.1080\/13880209.2022.2093385.","journal-title":"Pharm Biol"},{"key":"630_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.109835","volume":"354","author":"Q-N Wang","year":"2022","unstructured":"Wang Q-N, Yan Y-Z, Zhang X-Z, Lv J-X, Nie H-P, Wu J, et al. Rescuing effects of periostin in advanced glycation end-products (AGEs) caused osteogenic and oxidative damage through AGE receptor mediation and DNA methylation of the CALCA promoter. Chem Biol Interact. 2022;354:109835. https:\/\/doi.org\/10.1016\/j.cbi.2022.109835.","journal-title":"Chem Biol Interact"},{"key":"630_CR149","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12471","volume":"51","author":"M Zhang","year":"2018","unstructured":"Zhang M, Li Y, Rao P, Huang K, Luo D, Cai X, et al. Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway. Cell Prolif. 2018;51:e12471. https:\/\/doi.org\/10.1111\/cpr.12471.","journal-title":"Cell Prolif"},{"key":"630_CR150","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13287-022-03088-4","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Gao Y, Li Q, Cao H, Yang J, Cai X, et al. Downregulation of DNA methyltransferase-3a ameliorates the osteogenic differentiation ability of adipose-derived stem cells in diabetic osteoporosis via Wnt\/\u03b2-catenin signaling pathway. Stem Cell Res Ther. 2022;13:397. https:\/\/doi.org\/10.1186\/s13287-022-03088-4.","journal-title":"Stem Cell Res Ther"},{"key":"630_CR151","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s13287-024-04058-8","volume":"15","author":"Q Ying","year":"2024","unstructured":"Ying Q, Jiang Y, Sun C, Zhang Y, Gao R, Liu H, et al. AGEs impair osteogenesis in orthodontic force-induced periodontal ligament stem cells through the KDM6B\/Wnt self-reinforcing loop. Stem Cell Res Ther. 2024;15:431. https:\/\/doi.org\/10.1186\/s13287-024-04058-8.","journal-title":"Stem Cell Res Ther"},{"key":"630_CR152","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1080\/15592294.2022.2111759","volume":"17","author":"J-R Chen","year":"2022","unstructured":"Chen J-R, Caviness PC, Zhao H, Belcher B, Wankhade UD, Shankar K, et al. Maternal high-fat diet modifies epigenetic marks H3K27me3 and H3K27ac in bone to regulate offspring osteoblastogenesis in mice. Epigenetics. 2022;17:2209\u201322. https:\/\/doi.org\/10.1080\/15592294.2022.2111759.","journal-title":"Epigenetics"},{"key":"630_CR153","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202500767RRR","volume":"39","author":"PC Caviness","year":"2025","unstructured":"Caviness PC, Belcher B, Lazarenko OP, Chen JF, Blackburn ML, Chen J-R. Soy isoflavones prevent bone quality loss induced by high-fat diet in rats through epigenetic modifications. FASEB J. 2025;39:e71158. https:\/\/doi.org\/10.1096\/fj.202500767RRR.","journal-title":"FASEB J"},{"key":"630_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152042","volume":"774","author":"Z Wang","year":"2025","unstructured":"Wang Z, Tang Y, Liu Y, Zeng Y, Zhang M. ALKBH5 mediates FGF21 m6A demethylation in human bone marrow mesenchymal stem cells under high glucose conditions. Biochem Biophys Res Commun. 2025;774:152042. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152042.","journal-title":"Biochem Biophys Res Commun"},{"key":"630_CR155","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101610R","volume":"36","author":"Y Lin","year":"2022","unstructured":"Lin Y, Shen X, Ke Y, Lan C, Chen X, Liang B, et al. Activation of osteoblast ferroptosis via the METTL3\/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone loss. FASEB J. 2022;36:e22147. https:\/\/doi.org\/10.1096\/fj.202101610R.","journal-title":"FASEB J"},{"key":"630_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2026.150917","volume":"350","author":"X-W Liu","year":"2026","unstructured":"Liu X-W, Zhang S-B, Xu H-W, Lu J-H, Chang S-J, Huang S-S, et al. ETS transcription factor 1-insulin-like growth factor 2 mRNA-binding protein 2-interferon-induced transmembrane protein 3 pathway promotes ferroptosis-driven osteoblast senescence in diabetic osteoporosis. Int J Biol Macromol. 2026;350:150917. https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150917.","journal-title":"Int J Biol Macromol"},{"key":"630_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110510","volume":"122","author":"X Shen","year":"2023","unstructured":"Shen X, Lan C, Lin Y, Zhang F, Zhang Y, Chen M, et al. Suppression of TLR4 prevents diabetic bone loss by regulating FTO-mediated m6A modification. Int Immunopharmacol. 2023;122:110510. https:\/\/doi.org\/10.1016\/j.intimp.2023.110510.","journal-title":"Int Immunopharmacol"},{"key":"630_CR158","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13174","volume":"55","author":"S Peng","year":"2022","unstructured":"Peng S, Gao Y, Shi S, Zhao D, Cao H, Fu T, et al. LncRNA-AK137033 inhibits the osteogenic potential of adipose-derived stem cells in diabetic osteoporosis by regulating Wnt signaling pathway via DNA methylation. Cell Prolif. 2022;55:e13174. https:\/\/doi.org\/10.1111\/cpr.13174.","journal-title":"Cell Prolif"},{"key":"630_CR159","doi-asserted-by":"publisher","first-page":"1625944","DOI":"10.3389\/fendo.2025.1625944","volume":"16","author":"M-Q Qiao","year":"2025","unstructured":"Qiao M-Q, Wang B, Fan J-P, Gao F, Wang S-J, Guo S-Y, et al. Inhibition of histone methyltransferase G9a promotes the osteogenic potential of bone-derived stem cells in diabetic-osteoporosis by regulating the LINC00657\/miR-204-5p\/IGFBP5 pathway. Front Endocrinol (Lausanne). 2025;16:1625944. https:\/\/doi.org\/10.3389\/fendo.2025.1625944.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"630_CR160","doi-asserted-by":"publisher","first-page":"13441","DOI":"10.1038\/s41598-024-64391-z","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li M, Lou P, Zhang M, Shou D, Tong P. miRNA-seq analysis of high glucose induced osteoblasts provides insight into the mechanism underlying diabetic osteoporosis. Sci Rep. 2024;14:13441. https:\/\/doi.org\/10.1038\/s41598-024-64391-z.","journal-title":"Sci Rep"},{"key":"630_CR161","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.yexcr.2017.02.021","volume":"352","author":"C Wang","year":"2017","unstructured":"Wang C, Shan S, Wang C, Wang J, Li J, Hu G, et al. Mechanical stimulation promote the osteogenic differentiation of bone marrow stromal cells through epigenetic regulation of Sonic Hedgehog. Exp Cell Res. 2017;352:346\u201356. https:\/\/doi.org\/10.1016\/j.yexcr.2017.02.021.","journal-title":"Exp Cell Res"},{"key":"630_CR162","doi-asserted-by":"publisher","unstructured":"Shi Q, Song Y, Cao J, Na J, Yang Z, Chen X, et al. Inhibition of mitochondrial fission reverses simulated microgravity-induced osteoblast dysfunction by enhancing mechanotransduction and epigenetic modification. Research (Wash D C). 2025;8:0602. https:\/\/doi.org\/10.34133\/research.0602.","DOI":"10.34133\/research.0602"},{"key":"630_CR163","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12967-024-06050-5","volume":"23","author":"D Zhong","year":"2025","unstructured":"Zhong D, Li X, Yin Z, Chen P, Li Y, Tian J, et al. Circ-ITCH promotes the ubiquitination degradation of HOXC10 to facilitate osteogenic differentiation in disuse osteoporosis through stabilizing BRCA1 mRNA via IGF2BP2-mediated m6A modification. J Transl Med. 2025;23:376. https:\/\/doi.org\/10.1186\/s12967-024-06050-5.","journal-title":"J Transl Med"},{"key":"630_CR164","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00018-025-05588-x","volume":"82","author":"L Xu","year":"2025","unstructured":"Xu L, Zhang L, Sun Q, Zhang X, Zhang J, Zhao X, et al. Melatonin antagonizes bone loss induced by mechanical unloading via IGF2BP1-dependent m6A regulation. Cell Mol Life Sci. 2025;82:60. https:\/\/doi.org\/10.1007\/s00018-025-05588-x.","journal-title":"Cell Mol Life Sci"},{"key":"630_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217939","volume":"631","author":"M Zhang","year":"2025","unstructured":"Zhang M, Tang C, Li S, Jiang X, Li B, Chen Y, et al. NSUN2-mediated m5C modification of KDM6B mRNA enhances osteoclast differentiation and promotes breast cancer bone metastasis. Cancer Lett. 2025;631:217939. https:\/\/doi.org\/10.1016\/j.canlet.2025.217939.","journal-title":"Cancer Lett"},{"key":"630_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217047","volume":"597","author":"S Wang","year":"2024","unstructured":"Wang S, Xu L, Wang D, Zhao S, Li K, Ma F, et al. YTHDF1 promotes the osteolytic bone metastasis of breast cancer via inducing EZH2 and CDH11 translation. Cancer Lett. 2024;597:217047. https:\/\/doi.org\/10.1016\/j.canlet.2024.217047.","journal-title":"Cancer Lett"},{"key":"630_CR167","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70091","volume":"14","author":"T Tamura","year":"2025","unstructured":"Tamura T, Yamamoto T, Kogure A, Yoshioka Y, Yamamoto Y, Sakamoto S, et al. Extracellular vesicles from prostate cancer-corrupted osteoclasts drive a chain reaction of inflammatory osteolysis and tumour progression at the bone metastatic site. J Extracell Vesicles. 2025;14:e70091. https:\/\/doi.org\/10.1002\/jev2.70091.","journal-title":"J Extracell Vesicles"},{"key":"630_CR168","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s42003-024-06918-8","volume":"7","author":"M Yu","year":"2024","unstructured":"Yu M, Cai Z, Zhang J, Zhang Y, Fu J, Cui X. Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma. Commun Biol. 2024;7:1249. https:\/\/doi.org\/10.1038\/s42003-024-06918-8.","journal-title":"Commun Biol"},{"key":"630_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110058","volume":"119","author":"N Guo","year":"2023","unstructured":"Guo N, Song Y, Zi F, Zheng J, Cheng J. Abnormal expression pattern of lncRNA H19 participates in multiple myeloma bone disease by unbalancing osteogenesis and osteolysis. Int Immunopharmacol. 2023;119:110058. https:\/\/doi.org\/10.1016\/j.intimp.2023.110058.","journal-title":"Int Immunopharmacol"},{"key":"630_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115953","volume":"44","author":"H Wang","year":"2025","unstructured":"Wang H, Guo J, Li L, Xie H, Zhang J, Zhang W, et al. FTO SUMOylation regulates the differentiation of bone marrow mesenchymal stromal cells in inflammatory bowel disease-induced bone loss. Cell Rep. 2025;44:115953. https:\/\/doi.org\/10.1016\/j.celrep.2025.115953.","journal-title":"Cell Rep"},{"key":"630_CR171","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jare.2024.07.031","volume":"72","author":"R Yang","year":"2025","unstructured":"Yang R, Yu W, Lin L, Cui Z, Tang J, Li G, et al. NAT10 promotes osteoclastogenesis in inflammatory bone loss by catalyzing Fos mRNA ac4C modification and upregulating MAPK signaling pathway. J Adv Res. 2025;72:303\u201317. https:\/\/doi.org\/10.1016\/j.jare.2024.07.031.","journal-title":"J Adv Res"},{"key":"630_CR172","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13018-022-03072-x","volume":"17","author":"Y Feng","year":"2022","unstructured":"Feng Y, Ding L, Li L. LPS-inducible circAtp9b is highly expressed in osteoporosis and promotes the apoptosis of osteoblasts by reducing the formation of mature miR-17-92a. J Orthop Surg Res. 2022;17:193. https:\/\/doi.org\/10.1186\/s13018-022-03072-x.","journal-title":"J Orthop Surg Res"},{"key":"630_CR173","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13075-026-03798-7","volume":"28","author":"H Zhao","year":"2026","unstructured":"Zhao H, Shu J, Yu F, Lu C, Li L, Zhao N, et al. LncRNA MIAT inhibits osteoblast differentiation and function in rheumatoid arthritis via let-7i-5p\/ CKIP-1 axis. Arthritis Res Ther. 2026;28:98. https:\/\/doi.org\/10.1186\/s13075-026-03798-7.","journal-title":"Arthritis Res Ther"},{"key":"630_CR174","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrendo.2015.89","volume":"11","author":"JN Farr","year":"2015","unstructured":"Farr JN, Khosla S. Skeletal changes through the lifespan\u2013from growth to senescence. Nat Rev Endocrinol. 2015;11:513\u201321. https:\/\/doi.org\/10.1038\/nrendo.2015.89.","journal-title":"Nat Rev Endocrinol"},{"key":"630_CR175","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat Med. 2017;23:1072\u20139. https:\/\/doi.org\/10.1038\/nm.4385.","journal-title":"Nat Med"},{"key":"630_CR176","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1152\/physrev.00033.2015","volume":"97","author":"M Almeida","year":"2017","unstructured":"Almeida M, Laurent MR, Dubois V, Claessens F, O\u2019Brien CA, Bouillon R, et al. Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev. 2017;97:135\u201387. https:\/\/doi.org\/10.1152\/physrev.00033.2015.","journal-title":"Physiol Rev"},{"key":"630_CR177","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ygeno.2018.05.001","volume":"111","author":"J-G Letarouilly","year":"2019","unstructured":"Letarouilly J-G, Broux O, Clabaut A. New insights into the epigenetics of osteoporosis. Genomics. 2019;111:793\u20138. https:\/\/doi.org\/10.1016\/j.ygeno.2018.05.001.","journal-title":"Genomics"},{"key":"630_CR178","doi-asserted-by":"publisher","unstructured":"Weinstein RS. Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med. 2011;365:62\u201370. https:\/\/doi.org\/10.1056\/NEJMcp1012926.","DOI":"10.1056\/NEJMcp1012926"},{"key":"630_CR179","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","volume":"10","author":"LC Hofbauer","year":"2022","unstructured":"Hofbauer LC, Busse B, Eastell R, Ferrari S, Frost M, M\u00fcller R, et al. Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol. 2022;10:207\u201320. https:\/\/doi.org\/10.1016\/S2213-8587(21)00347-8.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"630_CR180","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00223-021-00836-1","volume":"110","author":"T Rolvien","year":"2022","unstructured":"Rolvien T, Amling M. Disuse osteoporosis: clinical and mechanistic insights. Calcif Tissue Int. 2022;110:592\u2013604. https:\/\/doi.org\/10.1007\/s00223-021-00836-1.","journal-title":"Calcif Tissue Int"},{"key":"630_CR181","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Cl\u00e9zardin","year":"2021","unstructured":"Cl\u00e9zardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101:797\u2013855. https:\/\/doi.org\/10.1152\/physrev.00012.2019.","journal-title":"Physiol Rev"},{"key":"630_CR182","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrendo.2010.190","volume":"6","author":"G Schett","year":"2010","unstructured":"Schett G, David J-P. The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol. 2010;6:698\u2013706. https:\/\/doi.org\/10.1038\/nrendo.2010.190.","journal-title":"Nat Rev Endocrinol"},{"key":"630_CR183","doi-asserted-by":"publisher","first-page":"11420","DOI":"10.1038\/s41467-025-66281-y","volume":"16","author":"C-T Ho","year":"2025","unstructured":"Ho C-T, Li L-H, Chang W-C, Wu H-H, Chen Y-H, Hung S-C. TRIM37-PARP1-TET1 axis maintains stemness and prevents osteoporosis by inhibiting DNMT1 alternative splicing via 5hmC regulation. Nat Commun. 2025;16:11420. https:\/\/doi.org\/10.1038\/s41467-025-66281-y.","journal-title":"Nat Commun"},{"key":"630_CR184","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59638-w","volume":"16","author":"L Xing","year":"2025","unstructured":"Xing L, Xu J, Gong M, Liu Y, Li X, Meng L, et al. Targeted disruption of PRC1.1 complex enhances bone remodeling. Nat Commun. 2025;16:4294. https:\/\/doi.org\/10.1038\/s41467-025-59638-w.","journal-title":"Nat Commun"},{"key":"630_CR185","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307388","volume":"11","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Qi G, He X, Yu Y, Cao Y, Zhang C, et al. Ferroptosis in osteocytes as a target for protection against postmenopausal osteoporosis. Adv Sci (Weinh). 2024;11:e2307388. https:\/\/doi.org\/10.1002\/advs.202307388.","journal-title":"Adv Sci (Weinh)"},{"key":"630_CR186","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2217\/epi-2021-0391","volume":"14","author":"L Lu","year":"2022","unstructured":"Lu L, Wang L, Wu J, Yang M, Chen B, Wang H, et al. DNMT3a promotes osteoblast differentiation and alleviates osteoporosis via the PPAR\u03b3\/SCD1\/GLUT1 axis. Epigenomics. 2022;14:777\u201392. https:\/\/doi.org\/10.2217\/epi-2021-0391.","journal-title":"Epigenomics"},{"key":"630_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-026-01727-4","author":"R-W Wu","year":"2026","unstructured":"Wu R-W, Lian W-S, Lin Y-H, Chen Y-S, Wang S-Y, Wu S-L, et al. Histone arginine demethylase JMJD7 promotes bone formation through regulating \u03b1-ketoglutarate metabolism. Cell Death Differ. 2026. https:\/\/doi.org\/10.1038\/s41418-026-01727-4.","journal-title":"Cell Death Differ"},{"key":"630_CR188","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cellsig.2017.03.004","volume":"34","author":"Y Dong","year":"2017","unstructured":"Dong Y, Song C, Wang Y, Lei Z, Xu F, Guan H, et al. Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2. Cell Signal. 2017;34:55\u201365. https:\/\/doi.org\/10.1016\/j.cellsig.2017.03.004.","journal-title":"Cell Signal"},{"key":"630_CR189","doi-asserted-by":"publisher","unstructured":"Choi JH, Jang AR, Park MJ, Kim DI, Park JH. Melatonin inhibits osteoclastogenesis and bone loss in ovariectomized mice by regulating PRMT1-mediated signaling. Endocrinology. 2021;162:bqab057. https:\/\/doi.org\/10.1210\/endocr\/bqab057.","DOI":"10.1210\/endocr\/bqab057"},{"key":"630_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1369","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Jiao G, You Y, Li X, Liu J, Sun Z, et al. Arginine methylation of PPP1CA by CARM1 regulates glucose metabolism and affects osteogenic differentiation and osteoclastic differentiation. Clin Transl Med. 2023;13:e1369. https:\/\/doi.org\/10.1002\/ctm2.1369.","journal-title":"Clin Transl Med"},{"key":"630_CR191","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jot.2024.08.008","volume":"48","author":"H Tang","year":"2024","unstructured":"Tang H, Du Y, Tan Z, Li D, Xie J. METTL14-mediated HOXA5 m6A modification alleviates osteoporosis via promoting WNK1 transcription to suppress NLRP3-dependent macrophage pyroptosis. J Orthop Translat. 2024;48:190\u2013203. https:\/\/doi.org\/10.1016\/j.jot.2024.08.008.","journal-title":"J Orthop Translat"},{"key":"630_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-94215-7","volume":"15","author":"G Hu","year":"2025","unstructured":"Hu G, Wen J, Yang H, Zhang K. Isoimperatorin improves osteoporosis by increasing YBX1 expression to promote BGLAP m5C modification. Sci Rep. 2025;15:9734. https:\/\/doi.org\/10.1038\/s41598-025-94215-7.","journal-title":"Sci Rep"},{"key":"630_CR193","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41598-023-29546-4","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhang H, Li Q, Zhang L, Chen L, Wang H, et al. Long non-coding RNA KCNQ1OT1 alleviates postmenopausal osteoporosis by modulating miR-421-3p\/mTOR axis. Sci Rep. 2023;13:2333. https:\/\/doi.org\/10.1038\/s41598-023-29546-4.","journal-title":"Sci Rep"},{"key":"630_CR194","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0345372","volume":"21","author":"S Gong","year":"2026","unstructured":"Gong S, Han L, Wang Y, Feng Y, Wang R, Zhang S, et al. Glucocorticoid-induced alterations in DNA methylation in the H19 promoter of bone marrow-derived mesenchymal stem cells are associated with the pathogenesis of osteonecrosis. PLoS ONE. 2026;21:e0345372. https:\/\/doi.org\/10.1371\/journal.pone.0345372.","journal-title":"PLoS ONE"},{"key":"630_CR195","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/1756-185X.14567","volume":"26","author":"H Hu","year":"2023","unstructured":"Hu H, Guo X, Mu T, Song H. Long non-coding RNA telomerase RNA elements improve glucocorticoid-induced osteoporosis by EZH2 to regulate DKK1. Int J Rheum Dis. 2023;26:638\u201347. https:\/\/doi.org\/10.1111\/1756-185X.14567.","journal-title":"Int J Rheum Dis"},{"key":"630_CR196","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.2147\/IJN.S435301","volume":"18","author":"N Xu","year":"2023","unstructured":"Xu N, Cui G, Zhao S, Li Y, Liu Q, Liu X, et al. Therapeutic effects of mechanical stress-induced C2C12-derived exosomes on glucocorticoid-induced osteoporosis through miR-92a-3p\/PTEN\/AKT signaling pathway. Int J Nanomedicine. 2023;18:7583\u2013603. https:\/\/doi.org\/10.2147\/IJN.S435301.","journal-title":"Int J Nanomedicine"},{"key":"630_CR197","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s13577-022-00741-1","volume":"35","author":"W Liu","year":"2022","unstructured":"Liu W, Li G, Li J, Chen W. Long noncoding RNA TRG-AS1 protects against glucocorticoid-induced osteoporosis in a rat model by regulating miR-802-mediated CAB39\/AMPK\/SIRT-1\/NF-\u03baB axis. Hum Cell. 2022;35:1424\u201339. https:\/\/doi.org\/10.1007\/s13577-022-00741-1.","journal-title":"Hum Cell"},{"key":"630_CR198","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3892\/mmr.2019.10497","volume":"20","author":"X-B Wang","year":"2019","unstructured":"Wang X-B, Li P-B, Guo S-F, Yang Q-S, Chen Z-X, Wang D, et al. circRNA_0006393 promotes osteogenesis in glucocorticoid-induced osteoporosis by sponging miR-145-5p and upregulating FOXO1. Mol Med Rep. 2019;20:2851\u20138. https:\/\/doi.org\/10.3892\/mmr.2019.10497.","journal-title":"Mol Med Rep"},{"key":"630_CR199","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.7150\/thno.63749","volume":"11","author":"J Behera","year":"2021","unstructured":"Behera J, Ison J, Voor MJ, Tyagi N. Probiotics stimulate bone formation in obese mice via histone methylations. Theranostics. 2021;11:8605\u201323. https:\/\/doi.org\/10.7150\/thno.63749.","journal-title":"Theranostics"},{"key":"630_CR200","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s10565-022-09713-5","volume":"39","author":"D Zhang","year":"2023","unstructured":"Zhang D, Du J, Yu M, Suo L. Urine-derived stem cells-extracellular vesicles ameliorate diabetic osteoporosis through HDAC4\/HIF-1\u03b1\/VEGFA axis by delivering microRNA-26a-5p. Cell Biol Toxicol. 2023;39:2243\u201357. https:\/\/doi.org\/10.1007\/s10565-022-09713-5.","journal-title":"Cell Biol Toxicol"},{"key":"630_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116118","volume":"222","author":"J Wu","year":"2024","unstructured":"Wu J, Li X, Nie H, Shen Y, Guo Z, Huihan Chu C, et al. Phytic acid promotes high glucose-mediated bone marrow mesenchymal stem cells osteogenesis via modulating circEIF4B that sponges miR-186-5p and complexes with IGF2BP3. Biochem Pharmacol. 2024;222:116118. https:\/\/doi.org\/10.1016\/j.bcp.2024.116118.","journal-title":"Biochem Pharmacol"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00630-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00630-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00630-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:19:29Z","timestamp":1792574369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00630-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":201,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00630-1","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This manuscript is a review article and does not involve any original human or animal studies conducted by the authors.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"221"}}